Sort
82,697 grants matching “vaccine development”
Mechanisms of repeated control of acute hepatitis C infection in humans
$1,135,370Andrea L Cox · Johns Hopkins University · U19 · FY2019 · AI
Immune correlates of protection
$1,135,344Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Modeling human hepatotropic infections in complex tissue organoids
$1,135,336Charles M. Rice · Rockefeller University · R01 · FY2009 · DK
University of Rochester HIV/AIDS Clinical Trials Unit
$1,135,210Michael C Keefer · University Of Rochester · UM1 · FY2015 · AI
Miami Treatment and Prevention Clinical Trials Unit (CTU)
$1,135,209Margaret A Fischl · University Of Miami School Of Medicine · UM1 · FY2015 · AI
International Studies Of Acquired Immune Deficiency Syndrome (AIDS)
$1,135,193Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Studies on Arthropod Vectors of Disease
$1,135,033Robert Gwadz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
CPTR - Mass Spectrometry Unit
$1,134,792Lisa Jenkins · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSES
$1,134,588Rustom Noshir Antia · Emory University · U01 · FY2024 · AI
RBD recombinant protein-based SARS vaccine for biodefense
$1,134,359Peter J Hotez · Baylor College Of Medicine · R01 · FY2014 · AI
Combining germline-targeting, B cell immunofocusing and Env-Ab co-evolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies
$1,134,239Raiees Ahmad Andrabi · Scripps Research Institute, The · R61 · FY2023 · AI
Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.
$1,133,980Mark M Davis · Stanford University · U19 · FY2020 · AI
Center of Excellence on Race, Ethnicity and Health Disparities Research
$1,133,771Stephen B. Thomas · Univ Of Maryland, College Park · P20 · FY2015 · MD
Large Scale T Cell Epitope Discovery for Burkholderia pseudomallei
$1,133,719Daniel Altmann · Imperial College Of Science, Technology And Medicine · N01 · FY2013 · AI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine
$1,133,663Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AI
Miami Pediatric AIDS Clinical Trials Unit
$1,133,574University Of Miami School Of Medicine · U01 · FY2002 · AI
NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIA
$1,133,466University Of California San Francisco · R01 · FY2000 · CA
Development of an Ad5 [E1-, E2b-] HIV-1 vaccine for use in Ad5 Immunized Vaccinee
$1,133,414Frank R. Jones · Etubics Corporation · R44 · FY2011 · AI
A novel vaccine against multidrug-resistant gonorrhea
$1,133,414Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
Papillomavirus Virion Proteins and Vaccines
$1,133,390Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Universal room temperature stable influenza nanovaccine
$1,132,987Balaji Narasimhan · Iowa State University · R01 · FY2020 · AI
WaNPRC MACACA NEMESTRINA SPF BREEDING COLONY
$1,132,800University Of Washington · U24 · FY2002 · RR
Immune responses to HPV infection and HPV vaccination
$1,132,580Mahboobeh Safaeian · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Preclinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$1,132,507Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2011 · AI
Biodefense and Emerging Infections Research Resources Repository
$1,132,106Raymond H. Cypess · American Type Culture Collection · N01 · FY2010 · AI